ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,907, issued on July 15, was assigned to GRUNENTHAL GMBH (Aachen, Germany).
"Substituted pyrrolidine amides III" was invented by Florian Jakob (Aachen, Germany), Jo Alen (Averbode, Belgium), Sebastian Kruger (Aachen, Germany), Daniela Friebe (Dusseldorf, Germany), Stephanie Hennen (Aachen, Germany) and Philipp Barbie (Berlin).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compounds according to general formula (I),which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor."
The patent was filed on ...